Screener
Dianthus Therapeutics DNTH Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $4.44B.
The source filing: Dianthus Therapeutics’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001690585-26-000022
FAQ
- What is Dianthus Therapeutics's market capitalization?
- Dianthus Therapeutics (DNTH) reported market capitalization of $4.44B in Q1 2026.
- How has Dianthus Therapeutics's market capitalization changed year-over-year?
- Dianthus Therapeutics's market capitalization increased by 662.4% year-over-year, from $582.75M to $4.44B.
- What is the long-term trend for Dianthus Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), Dianthus Therapeutics's market capitalization has grown at a 35.9% compound annual growth rate (CAGR), from $380.77M to $1.77B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Dianthus Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude